Company · CIK 1873093

# CytoMed Therapeutics Ltd

| CIK | [1873093](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001873093) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | U0 |
| Business address | Singapore |
| Listed | GDTC (Nasdaq) |
| First annual or quarterly report | 2023-05-01 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-288033 | Shelf Effective | 2025-06-13 | 2025-08-18 | 3 |
| 333-268456 | IPO Final prospectus | 2022-11-18 | 2023-04-17 | 8 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-08-18 | [424B5](https://www.sec.gov/Archives/edgar/data/1873093/000164117225024608/0001641172-25-024608-index.htm) Shelf takedown | 333-288033 | 0001641172-25-024608 |
| 2025-06-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1873093/999999999525001998/9999999995-25-001998-index.htm) Declared effective | 333-288033 | 9999999995-25-001998 |
| 2025-06-13 | [F-3](https://www.sec.gov/Archives/edgar/data/1873093/000164117225015075/0001641172-25-015075-index.htm) Shelf registered | 333-288033 | 0001641172-25-015075 |
| 2023-04-17 | [424B4](https://www.sec.gov/Archives/edgar/data/1873093/000149315223012534/0001493152-23-012534-index.htm) Final prospectus | 333-268456 | 0001493152-23-012534 |
| 2023-03-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1873093/999999999523000774/9999999995-23-000774-index.htm) Declared effective | 333-268456 | 9999999995-23-000774 |
| 2023-03-30 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1873093/000149315223009652/0001493152-23-009652-index.htm) Amendment | 333-268456 | 0001493152-23-009652 |
| 2023-03-28 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1873093/000149315223009156/0001493152-23-009156-index.htm) Amendment | 333-268456 | 0001493152-23-009156 |
| 2023-03-16 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1873093/000149315223007810/0001493152-23-007810-index.htm) Amendment | 333-268456 | 0001493152-23-007810 |
| 2023-02-21 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1873093/000149315223005626/0001493152-23-005626-index.htm) Amendment | 333-268456 | 0001493152-23-005626 |
| 2023-02-01 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1873093/000149315223003198/0001493152-23-003198-index.htm) Amendment | 333-268456 | 0001493152-23-003198 |
| 2022-11-18 | [F-1](https://www.sec.gov/Archives/edgar/data/1873093/000149315222032838/0001493152-22-032838-index.htm) Registration filed | 333-268456 | 0001493152-22-032838 |
| 2021-09-28 | [DRS](https://www.sec.gov/Archives/edgar/data/1873093/000149315221024011/0001493152-21-024011-index.htm) Draft made public | 377-05542 | 0001493152-21-024011 |

[All filings of this company](https://equitycapital.markets/filings?cik=1873093) · [CSV](https://equitycapital.markets/filings.csv?cik=1873093)

---
Source page: https://equitycapital.markets/company/1873093 · Data: U.S. SEC EDGAR · CC BY 4.0
